India's central bank is tightening as inflation bites — short Indian equities into the rate hike

Verdict: A Credible Macro Short With a Broken Trigger — Wait for the Repaired Entry

The macro thesis is the strongest thing here: per the Bloomberg piece published October 5, 2026, an India rate hike looms as the RBI drains excess liquidity, and both ETFs already trade near their range lows with real downside momentum — INDA at $46.52 with RSI at 27.6 and MACD at -0.68, EPHE at $22.64 with RSI at 30.2. But the trade is not executable yet: the compiled entry requires price below zero, a condition no equity ETF can ever print, the rule set produced zero trades across 1,235 daily bars over 60 months, and no robust parameter setup was established because the sensitivity run tested zero variants. There is also no fundamental cushion to analyze — every issuer metric is unavailable for both tickers as of the October 5, 2026 pull — and the only ownership disclosure is one provisional INDA holder reporting 34,998 shares for the September 30, 2026 period, so no positioning confirms the de-rate. The strongest point against: the two legs correlate at 0.398 and both carry negative standalone returns, so this is one concentrated emerging-Asia macro bet, not a diversified short, with an expected maximum drawdown near 28.2% on the basket. The verdict is wait — track a confirmed daily close below INDA's $47.04 or EPHE's $23.17 support, and shelve the short if either reclaims resistance ($48.00 / $23.00) with RSI back above 50.

Trade now: momentum is in place, the trigger is not

This is a watch-list setup, not an active signal: the rules were evaluated on real daily bars but did not open an entry. Three of the four entry conditions are already live on both legs. On INDA at $46.52, the ADX is 31.4 (above the 20 threshold), the RSI is 27.6 (below 50), and MACD is negative at -0.68. On EPHE at $22.64, the ADX is 36.5, the RSI is 30.2, and MACD is -0.51 — all in range. The one condition holding everything back is a compiled requirement that the closing price be below 0.0, which no equity index ETF can ever satisfy; the research author has flagged this as a compilation defect and requested a bounded optimization so the entry expresses the original breakdown thesis rather than an impossible price comparison. What this means for you today: do not chase the short on momentum alone. The market is already agreeing with the idea — both ETFs trade near their range lows (INDA 15.9% off its range high, EPHE 20.2% off) with strong downside momentum — but the entry framework is being repaired, and no robust parameter setup has been established yet, so there is no validated trigger threshold to act on. If the corrected entry fires, the risk framework is explicit: a hard stop at -2.0% on the position, a take-profit at +4.0% (a 2:1 reward-to-risk profile), support-based exits, and a maximum holding period of 90 daily bars, with positions capped at 25% of capital under fixed-risk sizing. Wait concretely: watch for a revised rule notification, and in the meantime track whether INDA holds its nearest support at $47.04 and EPHE its nearest support at $23.17. A confirmed daily close below those levels with momentum intact is exactly the state the repaired entry is meant to catch. One factual scope note: because the entry never fired in the evaluated windows, there are no trade statistics from this rule set to cite for win rate or drawdown expectations — the 2%-stop/4%-target geometry comes from the strategy's own exit rules, not from observed results.

A tightening RBI into rich valuations is a real de-rating setup

The macro anchor of this short is concrete and dated: per the Bloomberg piece published October 5, 2026, an India rate hike looms as the RBI grapples with excess liquidity, and the idea argues the tightening cycle is just beginning. The thesis logic is internally consistent — central bank liquidity drainage into elevated valuations historically compresses multiples fastest in rate-sensitive consumer and financial names, which is exactly what an India ETF and a Philippines ETF are concentrated in. Unlike the US, where the idea notes hike bets are fading and indices rally on Fed relief, India offers a cleaner macro short because the policy impulse and the equity de-rating driver point the same direction. The instruments themselves fit the profile the thesis describes. INDA is an India equity vehicle whose dividend record shows exactly the kind of rate-sensitive, lumpy payout stream you'd expect from an emerging-market index fund — payments swinging from $2.95 per share in 2021 to $0.08 in 2023, with a trailing twelve-month payout of zero as of the October 5, 2026 corporate-actions pull. EPHE, the Philippines leg, still pays (trailing twelve-month $0.679 per share, $0.48 paid at the June 15, 2026 ex-date), but both are pure beta vehicles on local equity markets with no fundamental cushion — meaning a central-bank-driven de-rate flows through to price essentially one-for-one. The rules not triggered status cuts in the short's favor on discipline: the entry has not fired in 1,235 evaluated daily bars over the 60-month window (and…

Scores

• Conviction score breakdown: 47
• Thesis support: 60
• Trade readiness: 25
• Risk quality: 40
• Trigger proximity: 75
• Fundamentals trend: 35

Watch items

• INDA — INDA close vs nearest support
• EPHE — EPHE close vs nearest support
• INDA — INDA RSI (14)
• EPHE — EPHE RSI (14)
• INDA — INDA trailing dividend per share
• EPHE — EPHE latest ex-date dividend